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Abstract
Background: Excessive sitting time is a risk factor for cardiovascular disease mortality and morbidity independent
of physical activity. This aim of this study was to evaluate the impact of a sit-stand workstation on sitting time, and
vascular, metabolic and musculoskeletal outcomes in office workers, and to investigate workstation acceptability
and feasibility.
Methods: A two-arm, parallel-group, individually randomised controlled trial was conducted in one organisation.
Participants were asymptomatic full-time office workers aged ≥18 years. Each participant in the intervention arm
had a sit-stand workstation installed on their workplace desk for 8 weeks. Participants in the control arm received
no intervention. The primary outcome was workplace sitting time, assessed at 0, 4 and 8 weeks by an ecological
momentary assessment diary. Secondary behavioural, cardiometabolic and musculoskeletal outcomes were assessed.
Acceptability and feasibility were assessed via questionnaire and interview. ANCOVA and magnitude-based inferences
examined intervention effects relative to controls at 4 and 8 weeks. Participants and researchers were not blind to
group allocation.
Results: Forty-seven participants were randomised (intervention n = 26; control n = 21). Relative to the control group at
8 weeks, the intervention group had a beneficial decrease in sitting time (−80.2 min/8-h workday (95 % CI = −129.0,
−31.4); p = 0.002), increase in standing time (72.9 min/8-h workday (21.2, 124.6); p = 0.007) and decrease in total
cholesterol (−0.40 mmol/L (−0.79, −0.003); p = 0.049). No harmful changes in musculoskeletal discomfort/pain
were observed relative to controls, and beneficial changes in flow-mediated dilation and diastolic blood pressure
were observed. Most participants self-reported that the workstation was easy to use and their work-related
productivity did not decrease when using the device. Factors that negatively influenced workstation use were
workstation design, the social environment, work tasks and habits.
Conclusion: Short-term use of a feasible sit-stand workstation reduced daily sitting time and led to beneficial
improvements in cardiometabolic risk parameters in asymptomatic office workers. These findings imply that if
the observed use of the sit-stand workstations continued over a longer duration, sit-stand workstations may
have important ramifications for the prevention and reduction of cardiometabolic risk in a large proportion of
the working population.
Trial registration: ClinicalTrials.gov NCT02496507.
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Background
Office-based workers can spend as much as 10–11 h of
a working day in a seated static posture [1], which repre-
sents an ergonomic hazard in the physical work environ-
ment [2]. Prolonged sitting and total sitting time are
associated with poor metabolic health [3], greater risk of
chronic diseases [4] and premature mortality [5]. Office
workers are therefore at increased risk of the negative
health outcomes associated with excessive sitting includ-
ing obesity, insulin resistance, cardiovascular disease,
depression and chronic back and neck pain [6]. The pre-
ventative role of moderate-to-vigorous physical activity
in the development of these conditions is irrefutable [7].
Critically however, the association between sitting time
and poor health remains after accounting for moderate-
to-vigorous physical activity [6]. This presents a compel-
ling rationale for public health programmes that target
sitting reduction in the workplace, as supported by a re-
cent expert statement [8]. Such programmes may also
help organisations reduce costs associated with health-
care and absenteeism [8].
The metabolic impact of breaking up prolonged sitting
with standing or light activity has been investigated in
acute, lab-based studies. Findings indicate favourable
changes in postprandial glucose and insulin excursions
[9, 10], suggesting there is potential for long-term sit
reduction interventions to significantly impact metabolic
disease risk. Two randomised controlled trials (RCTs)
have attempted to elucidate the impact of reduced
workplace sitting on surrogate health markers in
workers [11, 12]. Reduced sitting time caused positive
changes in high-density lipoprotein (HDL) cholesterol
concentrations following 3 months of using a sit-stand
workstation [11], however no changes in fasting blood
glucose, triglyceride and total cholesterol concentrations
were reported [11, 12]. This paucity of literature suggests
more research is warranted to better understand the meta-
bolic effects of reduced workplace sitting.
Although epidemiological evidence clearly highlights
the link between sitting time and cardiovascular morbid-
ity and mortality [5, 13, 14], the cardiovascular effects of
reducing sitting are yet to be assessed or confirmed
experimentally. Endothelial dysfunction, an early sign of
atherosclerotic disease, is considered a manifestation of
the compound impact of traditional risk factors. Import-
antly, endothelial dysfunction strongly and independ-
ently predicts cardiovascular events [15, 16] and is
reversed by interventions known to diminish cardiovas-
cular risk [17–19]. Assessment of endothelial function
allows presence and magnitude of cardiovascular risk to
be quantified prior to the development of overt disease
and in response to interventions targeting sitting time.
The sustainability of sit-stand workstations will be
determined by many factors, including feasibility and the
impact on work performance and practices. Some, albeit
limited evidence demonstrates inter-participant variation
in the way that sit-stand workstations are utilised in
offices [20, 21] and knowledge concerning feasibility and
acceptability of sit-to-stand workstations is suggestive of
inter-participant variation in determinants of initiation,
maintenance and discontinued use [20–22]. To date, no
trial has qualitatively assessed the acceptability and feasi-
bility of sit-stand workstations and associated quantita-
tive changes in behaviour, and markers of vascular and
metabolic disease risk in office workers. This data would
significantly add to the literature by providing a more
comprehensive understanding of the potential for sit-
stand workstations to be accepted and used in large-scale
workplace health programmes.
The aim of this 8-week intervention was to evaluate
changes in workplace sitting following installation of a
sit-stand workstation, compared to normal working
conditions. Associated effects on vascular and metabolic
disease risk markers were evaluated, as was the accept-
ability and feasibility of sit-stand workstations in a real
office setting.
Method
Study design
Data for this two-arm parallel-group RCT was collected
between October-December 2013. Treatment arms in-
cluded a sit-stand workstation intervention group (each
participant received a sit-stand workstation) and a control
group (usual practice). Liverpool John Moores University
ethically approved the trial. Participants and researchers
were not blinded to group allocation.
Recruitment
Organisation level
Office workers from one organisation (Liverpool John
Moores University, Liverpool, UK) were approached by
the research team in August-September 2013. Consent
was sought from 11 departmental managers for em-
ployee recruitment, installation of sit-stand workstations,
study contact and laboratory visits during work time
(Fig. 1). Departments were located across four buildings
with varying office layout (open-plan, individual offices
or a combination). Employees within the approached
departments were predominantly administrative staff.
Individual level
Via an email from the research team, all employees in
consenting departments received an overview of the study
and participant information sheet, and were invited to a
study information session (two sessions were organised
per department). Employees were given 2 weeks to
express interest. Interested employees were screened
for the following eligibility criteria by the research
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team via telephone: a) full-time member of staff, b)
access to a work telephone and desktop computer
with internet, c) no cardiovascular or metabolic dis-
ease, d) not taking any medication, e) not pregnant
and, f ) no planned absence >1 week during the trial.
If inclusion criteria were met, written informed con-
sent was obtained and baseline assessments sched-
uled. There was no racial or gender bias in the
selection of participants.
Group assignment and intervention
Following baseline assessments, participants were
assigned by one member of the research team to a
treatment arm using a randomised block design [23]
and random number table. Departments served as
blocks and participants within departments were ran-
domly assigned at the individual-level to an arm [23].
Assignment of individual participants within each de-
partment alternated between arms (i.e. intervention,
control, intervention, control…).
Intervention group
After baseline assessments, each participant had a sit-
stand workstation installed on their existing workplace
desk. A single (manufacturer’s suggested retail price £360)
or dual (£375) monitor WorkFit-A with Worksurface +
workstation was installed, dependent on the number of
monitors the participant had. The computer monitor(s)
and keyboard were housed on the workstation and the
workstation could be quickly raised up and down by hand
to enable seated or standing work. Participants were not
prescribed an amount of time to use the station. Ergotron
Ltd (www.ergotron.com) provided and installed the work-
stations in the standing position and gave participants
basic face-to-face training and ergonomic information on
correct workstation use. Participants received a web link
to manufacturer ergonomic guidelines via an email from
the research team (http://www.ergotron.com/tabid/305/
language/en-AU/Default.aspx). No other behaviour change
techniques were delivered, other than provision of the
workstation. After end-intervention data collection, manu-
facturer staff uninstalled the workstations.
Fig. 1 Consort flow diagram of enrolment, allocation, follow-up and analyses
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Control group
Participants were asked to maintain their normal work
practices and received no intervention. Participants were
offered the opportunity to have a sit-stand workstation
installed for 8 weeks after all data collection.
Data collection
At baseline, 4 weeks (mid-intervention) and 8 weeks (end-
intervention), participants’ office-based behaviours were
assessed via ecological momentary assessment (EMA)
diaries. At baseline and 8 weeks, participants attended
University laboratories in the morning for individual
assessments. Prior to laboratory visits, participants were
required to fast for a minimum of 8 h, avoid the consump-
tion of alcohol for 12 h, and avoid strenuous exercise for
24 h.
Outcome measures
Sitting, standing and walking time
The EMA diary assessed time spent sitting (primary out-
come), standing, walking and in other activities during
work hours over 5 days (Monday-Friday). At 15-minute
intervals participants used a paper-based diary to record
their main behaviour in response to the question: “What
are you doing right now?” The behaviour options were
sitting, standing, walking or other. If other was selected,
participants were instructed to write the activity they
were doing. EMA has been reported successfully in
recent behavioural research [24, 25], including workplace
research [26]. To promote compliance and minimise
data loss, participants used the EMA diary to record the
time they started and finished work each day, and con-
senting participants received one prompt to complete
the diary via text and/or email at the start of each day
from the research team.
Time spent in each behaviour per day (minutes/day:
sitting, standing, walking, other) was estimated by multi-
plying the frequency of recordings by 15, based on the
assumption that each behaviour episode occurred for
the entire 15 min [25]. This method is assumed to pro-
vide valid estimates of time spent in behaviour categories
when summed across a day, due to underestimation and
overestimation errors cancelling each other out [27]. A
diary day was considered valid if data entries were pro-
vided for ≥75 % of time spent at work (228/235 days at
baseline; 218/235 days at 4 weeks; 193/230 days at
8 weeks). Time spent in each behaviour was calculated
for each valid day and means were calculated from valid
days. In accordance with previous trials [11, 12, 22] out-
comes were standardised to an 8-hour work day to con-
trol for variations in work schedules [standardised
minutes = outcome minutes * 480/observed workplace
minutes]. To be retained for analyses, participants had
to provide ≥2 valid days at each time point (met by 23
intervention and 21 control participants).
Vascular outcomes
Endothelial dysfunction is an early and integral manifest-
ation of atherosclerotic disease [28] that strongly and inde-
pendently predicts cardiovascular events in asymptomatic
adults [15], and can be measured in the peripheral conduit
arteries non-invasively using flow-mediated dilation (FMD).
To this end, B-mode images of the brachial artery were
obtained in longitudinal section at a reproducible point in
the distal third of the upper arm using high resolution
ultrasonography (Terason, t3000, Teratech) and a 10–12-
MHz probe. Ultrasonic parameters were set to optimize the
luminal-arterial wall interface with the focal zone set to the
near wall. Once set, these parameters remained constant
throughout the session and the probe was held in a
constant position. Endothelium-dependent vasodilation
was assessed by measuring FMD in response to 5 min of
forearm ischaemia [29]. Briefly, a 1-min baseline measure-
ment was taken, then a pneumatic rapid cuff inflator
(Hokanson, Bellevue, U.S.A.), placed around the forearm
distal to the humeral epicondyle, was inflated to 220 mmHg
for 5 min [30]. Recording of the image ceased on inflation
of the cuff and recommenced 30 s prior to deflation.
Recording continued for a period of 3 min post cuff defla-
tion [30]. Data was analysed post hoc by custom designed
automated edge-detection and wall-tracking software, the
validity and reproducibility of which have been previously
demonstrated [31].
Carotid artery intima media thickness (cIMT) is an
early subclinical marker of structural atherosclerosis.
Increased cIMT independently predicts cardiovascular
events, is correlated with cardiovascular risk factors [32]
and as such cIMT is commonly used as a surrogate
marker of cardiovascular disease risk. cIMT was mea-
sured in the carotid artery using high resolution ultra-
sound from three different angles over six consecutive
cardiac cycles. Subjects were instructed to turn the head
laterally, by approximately 90° to the left, and the same
investigator undertook all measurements to ensure head
positioning and stability were maintained. The common
carotid artery was measured 2 cm proximal to the bulb-
ous. A two-dimensional image of the artery was obtained
with the near and far wall of the artery displayed as two
bright white lines separated by a hypoechogenic space.
Post-test analysis was performed using custom designed
automated edge-detection and wall-tracking software. A
region of interest of at least 1 cm was taken on the first
frame of every individual study, including both vessel
walls. Detection of the near and far wall lumen edges
and the far wall media-adventitia interface was per-
formed on all subsequent frames. The distance from the
leading edge of the first bright line of the far wall
Graves et al. BMC Public Health  (2015) 15:1145 Page 4 of 14
(lumen-intima interface) to the leading edge of the sec-
ond bright line (media-adventitia interface) indicated the
cIMT [33].
Blood sampling
Fasting blood samples were obtained from the antecubi-
tal vein of one arm via standard venepuncture technique
(Vacutainers Systems, Becton-Dickinson). Samples were
collected into vacutainers containing EDTA or lithium
heparin and stored on ice until centrifugation for 15 min
at 1500 g at 4 °C. Plasma aliquots were stored at −80 °C
for subsequent analysis. Plasma glucose, triglycerides
and total cholesterol concentrations were determined
spectrophotometrically using commercially available kits
(Randox Laboratories, Antrim, UK). Each sample was
analysed in duplicate.
Musculoskeletal outcomes
Using a questionnaire adapted from a previous trial [26],
participants rated their current level of discomfort or
pain at three sites (lower back, upper back, neck and
shoulders) on a Likert scale from 0 (no discomfort) to
10 (extremely uncomfortable).
Anthropometric, sociodemographic, work-related and office
environment characteristics
Using standard techniques [34] stature was measured to
the nearest 0.1 cm using a Leicester Height Measure and
body mass to the nearest 0.1 kg using a calibrated mech-
anical flat scale (both Seca Ltd, Birmingham, UK). Par-
ticipants wore light clothing and no shoes. Body mass
index (BMI) was calculated as mass divided by stature
(kg/m2). Participants self-reported sociodemographic,
work-related and office environment characteristics at
baseline (age, gender, ethnicity, marital status, education
attainment, smoking history, employment history, job
category, office layout, number of people in office).
Acceptability and feasibility
At 8 weeks, participants in the intervention arm com-
pleted a 19-item five-point Likert scale (1 strongly dis-
agree, 2 disagree, 3 neutral, 4 agree, 5 strongly disagree)
adapted from a previous trial [35] to assess the accept-
ability and feasibility of the sit-stand workstation.
Purposive sampling was employed to invite participants
of the intervention arm (n = 23) to attend a semi-
structured interview to discuss their experiences and
perspectives of using the workstation. Recruitment
emails were sent to all participants in the intervention
arm. Seven female participants responded and took part,
with interviews facilitated by the second author. The
seven participants interviewed did not significantly differ
to other intervention arm participants for any baseline
characteristic (p > 0.05). Focus groups were conducted
using a semi-structured interview guide to ensure
consistency in interview approach. The semi-structured
interview guides were designed to allow freedom in re-
sponse whilst also ensuring a degree of commonality
across the transcripts [36]. Interview questions were de-
veloped based upon a review of established literature [37]
and the identified aims of the study. Sample questions in-
cluded; “Please provide a brief overview of your experience
of using the sit-stand workstation?” (prompts included the
use of the workstation during the working day in terms of
choice of tasks to stand and complete, patterns of use,
time of day selected to stand) and “Can you reflect on the
influence of the workstation on your working practices?”.
Interviews took place in a familiar work setting, during
work hours and within a space where participants could
be overlooked but not overheard. Interviews lasted on
average 13 min (range 8–17 min), were audio recorded
and later transcribed verbatim. Verbatim transcripts were
read and re-read to allow familiarisation of the data. Con-
tent analysis techniques were used to identify core and
common themes in the data [38]. The process involved
reading and re-reading text and assigning broad thematic
codes. The lead (LG) and second author (RM) discussed
and debated emerging themes in the data with reference
to acceptability and feasibility of workstation use. There-
fore a combination of inductive and deductive techniques
was used to generate codes. Key emergent themes and
participant quotes have been used to ensure authenticity
in the represented data.
Sample size
Allowing for small drop out, the study aimed to recruit
25 participants per arm, and retain 23 participants per
arm. A sample size of 23 per arm was chosen a priori to
achieve 90 % power (alpha 5 %; two-tailed) to detect a
minimum difference of 60 min/8-h workday between
arms for workplace sitting time (primary outcome:
expected SD of 60 min/day). 60 min was selected based
on a recent protocol paper [39] and differences observed
in similar trials [22, 26]. Data collection for vascular and
metabolic outcomes would provide effect size estimates
for power calculations in subsequent trials.
Statistical analyses
Data was analysed using SPSS version 22 (IBM, New
York, USA) with the alpha level set at p ≤0.05. Interven-
tion effects were compared at 4 weeks (sitting, standing
and walking) and 8 weeks (all outcomes) from baseline
using analysis of covariance (ANCOVA). The variable
change score (4 or 8 weeks minus baseline) was the
dependent variable, with intervention arm (control vs
intervention) the independent variable. In all analyses,
covariates were the baseline value for the variable to con-
trol for any imbalances at baseline [40]. Anthropometric,
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sociodemographic, work-related and office-environment
characteristics were tested as potential confounders for all
outcomes. Confounders were entered as covariates if
significant associations (p ≤0.05) were observed with
changes in an outcome and the effect on the mean differ-
ence between groups exceeded 20 % [41]. For changes in
sitting, standing and walking time, baseline values of the
other two behaviours were tested as potential con-
founders, though no effects on the mean difference be-
tween groups exceeded 20 % [41]. Adjusted change scores
and 95 % confidence intervals (CIs) for the difference in
change between groups are presented unless stated other-
wise. Acceptability and feasibility data are reported as me-
dians and quartiles.
Missing data and intention-to-treat analysis
Due to participant withdrawal, lost EMA diaries or the
inability to conduct assessments, data were missing for
all outcomes (Fig. 1). Accordingly, a per-protocol analysis
was conducted and participants were excluded from ana-
lyses for outcomes they were missing data for. For work-
place sitting, standing and walking, the per-protocol
analysis was compared with an intention-to-treat analysis,
as a sensitivity analysis. To treat missing data, the fully
conditional imputation technique and ten imputation sets
were used due to a low rate of missing data [42]. Imput-
ation was based on all 47 randomized participants.
Minimum important differences analysis
Inferential statistics were ran using minimum clinically im-
portant difference principles, described elsewhere [43, 44].
Briefly, this approach makes inferences based on meaning-
ful magnitudes and is recommended alongside hypothesis
testing [43, 44]. A spreadsheet (see http://newstats.org/
generalize.html) computed the quantitative and qualitative
probability that the true effects were beneficial, trivial or
harmful, after the outcome statistic, its p value, and the
smallest/minimal important difference was entered. Mini-
mum important differences for sitting and standing were
60 min/day, and for walking 10 min/day, as guided by a re-
cent protocol paper [39] and differences in similar trials
[22, 26]. Minimum important differences for other out-
comes were determined through a distribution-based
method as a Cohen’s d (standardized difference between
change scores between groups) of 0.2 between-subjects
standard deviations (SDs) [45]. The SD of pooled baseline
data was used to negate the possibility of individual differ-
ences from the intervention influencing the SD at 8 weeks.
For each effect at 8 weeks, quantitative probabilities for
benefit, trivial and harm, and qualitative descriptors are re-
ported. Effects were interpreted as unclear if probabilities
for benefit and harm were >5 % [46].
Results
Forty-seven participants were randomised (Fig. 1). The
number of participants analysed for change in workplace
sitting time (primary outcome) at 4 and 8 weeks was 44
(23 intervention, 21 control). Participants were predom-
inantly White British women educated at the tertiary
level. Ten of the 47 participants were in health-related
posts, however potential bias to intervention responsive-
ness would have been minimised through the random-
isation method that evenly allocated these participants
to the treatment arms. Groups were comparable at base-
line except for a higher proportion of women in the
intervention arm (Tables 1, 2 and 3). For all participants
combined, sitting, standing and walking time occupied
80 ± 10 %, 9 ± 6 % and 11 ± 7 % of time spent at the
workplace, respectively.
Intervention effects
Sitting, standing and walking time
Findings were similar for the per-protocol (Table 2)
and intention-to-treat analyses. At 4 and 8 weeks
there were clear beneficial reductions in sitting time
(intention-to-treat: mean p = 0.001 and p = 0.002, re-
spectively) and increases in standing time (intention-
to-treat: mean p = 0.001 and p = 0.013, respectively) in
the intervention group relative to controls. No
between group differences were found for walking at
4 or 8 weeks (intention-to-treat: mean p = 0.290 and
p = 0.408, respectively).
Vascular outcomes
Although no statistically significant differences were ob-
served between groups for vascular outcomes, there was
a likely beneficial improvement for FMD (p = 0.203) and
a possibly beneficial improvement in diastolic blood
pressure (p = 0.293: Table 3) in the intervention group
relative to controls. Intervention effects for systolic
blood pressure and intima-media thickness were unclear
or likely trivial, respectively.
Blood sampling
A beneficial reduction in total cholesterol was observed in
the intervention group relative to the controls (p = 0.049:
Table 3). Intervention effects for fasting plasma glucose or
triglyceride concentrations were unclear.
Musculoskeletal and anthropometric outcomes
Although no statistically significant differences were ob-
served between groups for musculoskeletal discomfort/
pain, there was a likely beneficial reduction in the inter-
vention group relative to controls for upper back discom-
fort/pain (p = 0.096) and a possibly beneficial reduction in
neck and shoulder discomfort/pain (p = 0.155) (Table 3).
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No differences were observed between groups for body
mass or BMI (results not shown).
Acceptability and feasibility
From the 19-item Likert scale, participants reported
the sit-stand workstation easy to use and participants
were comfortable using the workstation in front of
others (Table 4). Most participants wanted further ad-
vice and guidance on how to use the workstation to
optimise health. A majority of participants reported
the sit-stand workstation did not decrease work-
related productivity or interfere with completion of
tasks. 33 % of participants reported more back pain
on days when using the workstation and 66 % re-
ported they would use the workstation at work if of-
fered to them by their employer.
Participants approached and experienced sit-stand
workstation use in a heterogeneous manner. Two broad
themes emerged from interview data which were patterns
of workstation use and factors that have the potential to
influence workstation use. With reference to patterns of
workstation use, findings demonstrated variation when
participants were permitted to self-select the standing op-
portunities. Some participants reported having used the
workstation for whole days:
“I did start off the first week of using it [the sit-stand
workstation] almost all of the day” (P7)
“The first day, 2 days, 3 days I used it [the sit-stand
workstation] pretty much all the time” (P3).
Whilst others reported self-selected patterning in rela-
tion to time of the day and hours/minutes of use:
“I did try and use it [the sit-stand workstation] at first
even like every half an hour or so, or like quite often
and then if I sat down I would try and use it again in
half an hour or so and then it got to, oh I’ll do 5 or
10 min every hour” (P4).
Participant two described how they used the worksta-
tion a lot in the first instance, but use declined over
time:
“I tried sort of like to do at least an hour in the
morning and an hour in the afternoon” (P2)
“I think towards the end I tend to sit down a lot … I
think it [use of the sit-stand workstation] just tailed off
in the end” (P2).
Subthemes to the factors that influenced worksta-
tion use included workstation design (n = 3), work
tasks (n = 5), the social environment (n = 5), habits (n = 5)
and alertness (n = 4). Feedback suggested interplay be-
tween the workstation design and type of task that could
Table 1 Baseline characteristics by group, presented as mean ± SD or % (n) of group
Intervention (n = 26) Control (n = 21) All (n = 47)
Age (years) 38.8 ± 9.8 38.4 ± 9.3 38.6 ± 9.5
Female 89 (23) 67 (14) 79 (37)
White British 92 (24) 100 (21) 96 (45)
Married 58 (15) 48 (10) 53 (25)
Time at current workplace
<1 year 0 (0) 0 (0) 0 (0)
1–3 years 8 (2) 19 (4) 13 (6)
>3 years 92 (24) 81 (17) 87 (41)
Tertiary education 100 (26) 91 (19) 96 (45)
Job category
Manager/Director 31 (8) 14 (3) 23 (11)
Clerical/Services/Other 69 (18) 86 (18) 77 (36)
Number of other people in the office
0 19 (5) 19 (4) 19 (9)
1–3 12 (3) 0 (0) 6 (3)
>3 69 (18) 81 (17) 75 (35)
Never smoked 77 (20) 76 (16) 77 (36)
Body mass (kg) 67.4 ± 13.8 70.5 ± 16.4 68.8 ± 14.9
Body mass index (kg/m2) 24.9 ± 4.4 24.7 ± 4.6 24.8 ± 4.4
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Table 2 Behavioural outcomes with adjusted between-group differences and quantitative and qualitative inferencesa
Intervention (n = 23) Control (n = 21) Adjusted change 0
to 4 week (95 % CI)b
Adjusted change 0
to 8 week (95 % CI)b
Probability (%)
the true effect is
beneficial / trivial
/ harmful
Qualitative
inference
(8 week)
(minutes/8-hour workday) Baseline 4 week 8 week Baseline 4 week 8 week
Sitting time 385.9 (57.6) 299.2 (93.4) 322.0 (99.3) 387.0 (41.0) 387.5 (78.0) 402.2 (47.9) −87.6 (−136.8 to −38.3)* −80.2 (−129.0 to −31.4) * 79/21/0 Benefit likely
Standing time 41.1 (35.0) 141.1 (98.0) 115.4 (111.6) 42.5 (26.0) 61.0 (76.2) 43.7 (50.2) 82.2 (36.5 to 127.8)* 72.9 (21.2 to 124.6)* 69/31/0 Benefit possible
Walking time 53.0 (41.2) 39.7 (33.4) 42.6 (42.3) 50.5 (24.2) 31.4 (24.4) 34.0 (29.1) 7.3 (−8.7 to 23.2) 7.1 (−12.1 to 26.3) 38/58/4 Possibly trivial
aBaseline, 4- and 8-week values are unadjusted mean (SD)
bChange scores and 95 % CIs are the differences between groups (relative to control) after adjustment by ANCOVA for the baseline value
*Significant (p <0.05)
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Table 3 Cardiometabolic and musculoskeletal outcomes with adjusted between-group differences and quantitative and qualitative inferencesa
Intervention Control Adjusted change 0 to
8 week (95 % CI)b
Probability (%)
the true effect
is beneficial /
trivial / harmful
Qualitative
inferenceBaseline 8 week Baseline 8 week
Vascular (n = 24 I, 19 C)
FMD (%) 5.98 (2.32) 7.13 (2.42) 5.88 (2.29) 6.13 (2.64) 0.97 (−0.55 to 2.50) 75/22/3 Benefit likely
cIMT (mm) 0.62 (0.07) 0.61 (0.07) 0.58 (0.08) 0.57 (0.08) 0.00 (−0.03 to 0.02) 13/84/3 Likely trivial
Systolic BP (mmHg) 119.1 (13.8) 117.1 (12.5) 117.9 (12.1) 117.3 (9.0) −1.6 (−7.0 to 3.7) 22/71/7 Unclear
Diastolic BP (mmHg) 73.5 (7.6) 68.9 (8.5) 71.8 (10.7) 70.5 (9.5) −2.5 (−7.2 to 2.2) 62/35/3 Benefit possible
Blood (n = 20 I, 17 C)
Glucose (mmol/L) 5.30 (0.79) 4.59 (0.84) 4.85 (0.62) 4.49 (0.55) −0.09 (−0.56 to 0.39) 37/49/14 Unclear
Triglycerides (mmol/L) 1.65 (0.70) 1.61 (0.74) 1.61 (0.64) 1.65 (0.73) 0.11 (−0.23 to 0.45) 6/55/39 Unclear
Cholesterol (mmol/L) 4.45 (0.98) 3.79 (1.05) 3.94 (0.86) 3.78 (0.74) −0.40 (−0.79 to −0.003)* 82/18/0 Benefit likely
Musculoskeletal discomfort/painc
(n = 25 I, 21 C)
Lower back 2.5 (2.2) 1.8 (2.0) 2.0 (2.0) 1.7 (1.8) −0.2 (−1.0 to 0.7) 35/50/15 Unclear
Upper back 1.9 (2.3) 1.1 (1.7) 1.2 (1.5) 1.6 (2.3) −0.9 (−1.9 to 0.2) 83/16/1 Benefit likely
Neck and shoulder 2.6 (2.5) 1.9 (2.4) 2.1 (2.0) 2.2 (2.4) −0.6 (−1.5 to 0.2) 63/36/1 Benefit possible
I intervention group, C control group, FMD flow-mediated dilation, cIMT carotid intima-media thickness, BP blood pressure
aBaseline and 8-weeks values are unadjusted mean (SD)
bChange scores and 95 % CIs are the differences between groups (relative to control) after adjustment by ANCOVA for the baseline value. Triglycerides ANCOVA additionally adjusted for marital status,
time at current workplace and job category
cValues denote the severity of discomfort or pain from 0 (No discomfort) to 10 (Extremely uncomfortable)
*Significant (p = 0.049)
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be completed when in a standing position. For example, it
was frequently reported that the workstation was too
small and restrictive to completing tasks that required
some desk space:
“Depends what work you had on because we use files a
lot and it [the sit-stand workstation] wasn’t you know
very good for with files and things were you tend to sit
down” (P2)
“Some duties couldn’t be performed you know with the
device up you know maybe like filing you know
different sort of paper based work” (P5)
Further negative factors reported in relation to
workstation design included the non-sturdy nature of
the station:
“I thought it [the sit-stand workstation] was a really
poor design. Just the way it bounced about and the
screen kept moving and cords getting in the way and
all this” (P1)
The social environment had both a positive and nega-
tive impact upon workstation use. Some participants
noted trepidation and feeling self-conscious in an envir-
onment where colleagues were working in seated posi-
tions. In addition there was a degree of consideration of
others in the environment as a result of them standing
whilst others were sitting.
“Initially we were like uh God I’m standing up
everyone else is sitting down …….. some people just felt
a bit self-conscious erm just because they were stand-
ing up and everyone else around them wasn’t maybe
that made them feel uncomfortable (P3)
“If people were coming in to see these people (colleagues
in close proximity) I sat down not to be a distraction so
they can concentrate on what they’re doing” (P6)
Table 4 Acceptability and feasibility of sit-stand workstations (1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree,
5 = strongly agree)
Questions Quartile 1 Median Quartile 3
The sit-stand workstation is easy to use 4.0 4.0 5.0
I would use the sit-stand workstation as an alternative to be active on days
that the weather is bad
2.0 3.0 4.0
I felt comfortable using the sit-stand workstation in the presence of others
at my work
3.5 4.0 5.0
My work-related productivity decreased while using the sit-stand workstation 2.0 2.0 3.0
The quality of my work decreased while using the sit-stand workstation 2.0 2.0 3.0
The sit-stand workstation interfered with my daily work-related tasks 2.0 2.0 4.0
I could conduct normal computer-related tasks while using the sit-stand
workstation
3.0 4.0 5.0
I could read comfortably while using the sit-stand workstation 2.3 4.0 4.0
I was more tired on days I used the sit-stand workstation 2.0 2.0 3.0
I had more back pain on days I used the sit-stand workstation 1.3 2.0 4.0
I had more joint pain on days I used the sit-stand workstation 2.0 2.0 2.0
I had more muscle aches on days I used the sit-stand workstation 1.3 2.0 3.0
My physical activity increased while at work as a result of the sit-stand
workstation
3.0 4.0 4.8
The time I spent being sedentary decreased while at work as a result of
the sit-stand workstation
3.0 4.0 5.0
My physical activity increased outside of work as a result of the sit-stand
workstation
2.0 2.5 3.0
If I were offered a sit-stand workstation by my employer, I would use it while
at work
2.3 4.0 5.0
I used the sit-stand workstation at consistent and regular intervals during the
working day
2.0 3.0 4.0
I would welcome further advice and guidance for using the sit-stand workstation
to optimise health gains
3.3 4.0 5.0
I would use a sit-stand workstation while at home 2.0 2.0 3.0
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Findings also identified cases of support from peers
using the desks and also prompting for such use in ob-
serving the behaviour of peers.
“You would see someone else pop up and use theirs so
you would think, oh yeah I’ll use mine” (P4)
Once the initial novelty of using the standing worksta-
tion had worn off, participants identified difficulty in re-
membering to work in the standing position and
reverted to old habits of sitting:
“After a couple of weeks you started to decline, so there
was almost like a novelty effect and then people were
too busy to think about standing so they just reverted
to sitting.” (P1)
“I got back into my old working habits of just sitting
down again and then just sort of forgot that I had it
and just I’d realise halfway through the afternoon that
I hadn’t stood up today but I think like just back to
old habits so you’re used to sitting down a lot.” (P2)
Perceived concentration and alertness also potentially
influenced workstation use, for example some partici-
pants indicated they felt better able to concentrate when
sitting:
“I don’t know whether standing up and being able to
see everyone more was a bit of a distraction as well
but yeah I did find I couldn’t concentrate as much
[when standing] and I’d need I think it’s just a natural
thing to sit down and have all your things around
you” (P4).
In contrast some participants observed heightened
alertness and enhanced productivity when standing:
“I did feel like a bit more awake” (P2)
“I think it [standing] kind of makes me more
productive straight away” (P3).
Discussion
To our knowledge, this was the first RCT to use qualita-
tive and quantitative methods to evaluate the feasibility
and acceptability of sit-stand workstations and the
impact on behavioural, cardiometabolic and musculo-
skeletal outcomes in asymptomatic office workers. The
findings suggest that sit-stand workstations are a feasible
tool for reducing daily sitting time and improving car-
diometabolic risk over 8 weeks. Most participants self-
reported that the workstation was easy to use and their
work-related productivity did not decrease when using
the device. Consistent with previous trials [11, 12, 22, 26]
the magnitude of the decrease in sitting time was similar
to the magnitude of the increase in standing time, and the
variation in sitting reduction across studies (33–137 min/
day) is likely due to different trial designs and the hetero-
geneity of samples and sitting time assessment method.
Investigations on the long-term use of sit-stand worksta-
tions are now required to understand the sustainability of
these changes in office behaviour.
Beneficial changes in cardiometabolic outcomes were
found after only 8 weeks of using a sit-stand workstation.
Observed reductions in total cholesterol are an important
finding since total cholesterol concentration is positively
associated with risk of developing coronary heart disease
[47]. Similarly, the beneficial changes observed for
FMD may have clinical importance, as FMD is a sur-
rogate marker of vascular endothelial function that
strongly and independently predicts future cardiovas-
cular events [15, 16]. Finally, while the possibly bene-
ficial change in diastolic blood pressure in the present
trial is contrary to a trial that found a potentially
negative change in diastolic blood pressure, that trial
lasted only 4 weeks [12]. These collective findings for
cholesterol, FMD and diastolic blood pressure imply
that if the observed use of the workstation continued
over a longer duration, sitting reduction via sit-stand
workstations could have important ramifications for
the prevention and reduction of cardiometabolic risk
in a large proportion of the population [15, 16].
Findings from the musculoskeletal survey suggest sit-
stand workstations did not increase discomfort or pain
in the present sample. Instead, possibly beneficial reduc-
tions in upper back, and neck and shoulder discomfort/
pain were observed. This is consistent with sit-stand
workstation trials that observed reductions in upper back
and neck pain [26] and decreased neck, knee and ankle/
feet symptoms [22]. In contrast, one trial did report in-
creased symptoms for shoulder pain after 12 weeks of sit-
stand workstation use [22] and acceptability data in the
present trial suggested some participants experienced dis-
comfort when using the workstation, though this appears
due to excessive and inappropriate use. Accordingly,
while the majority of the literature suggests sit-stand
workstations have little to no detrimental impact on
musculoskeletal outcomes in the short term, a greater
understanding of the long-term impact of sit-stand
workstations on musculoskeletal outcomes is required,
and providing workers with more comprehensive ad-
vice and guidance on safe and optimal use for health
is supported by our findings.
The qualitative data provided new insights into partici-
pant’s experiences and barriers to sit-stand workstation
use [20–22]. Patterns of workstation use varied across
participants, and an interaction between workstation de-
sign and task type appeared to influence how
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participants made use of the standing feature. For ex-
ample, completing paper-based and filing tasks were dif-
ficult when standing due to a lack of workstation space.
Researchers and practitioners may wish to consider the
work tasks typically completed by the targeted workforce
when deciding the type of sit-stand workstation to im-
plement in workplaces (e.g. sit-stand workstation vs. sit-
stand desk). Future research could also examine changes
in perceived concentration and alertness across task type
over time, as some workers cited that they completed
work in a seated posture to facilitate concentration and
ultimately task completion.
The social environment and in particular the presence
and actions of others were reported to support and deter
standing work. For example, seeing co-workers standing
prompted a transition from seated to standing work,
while other workers cited feelings of self-consciousness
as a reason to stay seated. Future trials could examine
the effect of additional intervention strategies (e.g. work-
place champions, wider workforce education on the
intervention and its aims) to the simple provision of a
standing workstation. Such strategies may additionally
support sustained use of the workstation, and prevent
workers from reverting back to the habit of seated work-
ing, which was observed in the present trial.
With regard to the design of future sit-stand worksta-
tion trials, sitting time data from this study has import-
ant implications. Previous parallel-group trials have used
cluster randomisation to minimise treatment contamin-
ation on sitting and standing time between treatment
arms. Though cluster randomisation is logical in multi-
component interventions that include organisational-
and individual-level strategies, treatment contamination
was previously unknown in single-level trials using sit-
stand workstations. The current trial demonstrates that
sitting time in the control group did not drop below
baseline values over 8 weeks and statistically significant
point estimates are comparable to a previous cluster
RCT of similar design [11]. It is important to note that
this study only measured one form of contamination,
and did not for example assess if participants passed on
ergonomic information or the workstation to control
participants, however this is unlikely. Therefore, whilst
further research is required to confirm these findings,
the use of individual rather than cluster randomisation
may be appropriate in future single-level trials that pro-
vide sit-stand workstations in an office setting. Individual
compared to cluster randomisation will increase statis-
tical power [23] and avoid factors associated with cluster
randomisation, including recruitment bias, the need for
larger samples, and the increased cost, length and com-
plexity of a trial [48].
Strengths of this study were the RCT design, objective
measurement of novel cardiometabolic outcomes,
investigation of workstation acceptability and feasibil-
ity, control of confounding factors, and the use of
magnitude-based inferences alongside traditional hy-
pothesis testing. However, limitations were evident.
Self-reporting activity places a higher burden on par-
ticipants and may not produce estimates as accurate
as accelerometers such as ActivPal. However, baseline
sitting, standing and walking time were comparable to
trials using accelerometers [11, 12, 22] and the current
trial used more rigorous inclusion criteria for activity
monitoring (≥2 valid days at each time point) than the
aforementioned trials that had no minimum requirement
for the number of valid days at any time point. The RCT,
though of similar [11, 22] or greater [12, 26] duration to
previous trials, did not investigate the long-term sustain-
ability and impact of sit-stand workstations, or unintended
changes in leisure time behaviour. Finally, a minority of
participants were in health-related posts and a majority of
participants were White British, non-smoking, normal
weight women with a tertiary education qualification.
While the sample may not be wholly representative of
the population intended to be analysed, the sample held
diverse office-based job roles across various depart-
ments, and baseline sitting time was comparable to
other general-office based populations, [12, 49] increas-
ing the generalizability of findings.
Conclusion
Short-term use of a feasible sit-stand workstation re-
duced daily sitting time and led to beneficial improve-
ments in cardiometabolic risk parameters in
asymptomatic office workers. Most participants self-
reported that the workstation was easy to use and their
work-related productivity did not decrease when using
the workstation, however factors reported to negatively
influence workstation use included workstation design,
the social environment, work tasks and habits. If the
observed workstation use and health benefits are main-
tained or improved over longer periods, sit-stand work-
stations may offer health benefits for a large proportion
of the working population and economic benefits for
organisations through enhanced employee health and
wellbeing. Research should elucidate whether long-term
use of sit-stand workstations leads to sustained reduc-
tions in workplace sitting, further improvements in the
reported surrogates of cardiovascular and metabolic
disease risk, and economic benefits for organisations.
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